BICR in New Therapeutic Lung Cancer Trials
NCT05038826 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1833
Last updated 2023-03-14
Summary
Double reads in blinded independent central reviews (BICRs) are recommended to control the quality of trials but they are prone to discordances. We analyzed inter-reader discordances in a pool of lung cancer trials using RECIST 1.1.
Conditions
Sponsors & Collaborators
-
Median Technologies
lead INDUSTRY
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-02-01
- Primary Completion
- 2021-08-10
- Completion
- 2021-12-01
Countries
- France
Study Locations
More Related Trials
-
Radiomics for prEdiction of lunG cAncer biologY
NCT05819905 ·Status: UNKNOWN
-
Evaluation of the Feasibility and Clinical Relevance of Liquid Biopsy in Patients With Suspicious Metastatic Lung Cancer
NCT03721120 ·Status: COMPLETED ·Phase: NA
-
Consistency Analysis of PD-L1s in Advanced NSCLC Tissues and in Plasma Exosomes Before and After Radiotherapy
NCT02869685 ·Status: COMPLETED ·Phase: NA
-
Exhaled Breath Biomarkers in Lung Cancer
NCT01386203 ·Status: UNKNOWN
-
Molecular Analysis of Oncogenes and Resistance Mechanisms in Lung Cancer
NCT01580982 ·Status: RECRUITING
-
Multicenter Validation of the Sensitivity of Theranostic ALK Rearrangement Detection by FISH Analysis and Prevalence of Escaping Mutations in Circulating Tumor Cells for the Non-invasive Management of Lung Cancer Patients
NCT02372448 ·Status: COMPLETED ·Phase: NA
-
Community-Based Engagement to Improve Lung Cancer Screening and Outcomes: The "Our Lungs Our Health" Study
NCT06909981 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Identifying Biomarkers for Lung Cancer Using Tissue Samples From Patients With Lung Cancer and From Healthy Participants
NCT00899028 ·Status: COMPLETED
-
Post-Surgical Non-Small Cell Lung Cancer (NSCLC) Follow-up
NCT00198341 ·Status: COMPLETED ·Phase: NA
-
Lung Cancer Information Study (LCIS-R01)
NCT01924416 ·Status: COMPLETED ·Phase: NA
-
Improving Detection of Early Lung Cancer in a Diverse Population (IDEAL) Study
NCT06628102 ·Status: RECRUITING ·Phase: NA
-
Comprehensive Demographics and Clinical Profile of NSCLC Patients
NCT06725537 ·Status: NOT_YET_RECRUITING
-
Understanding Non-small Cell Lung Cancer Patient Characteristics, Treatment Patterns and Outcomes
NCT07215026 ·Status: COMPLETED
-
Non-Invasive Biomarkers For Early Detection Of Lung Cancers
NCT01580332 ·Status: COMPLETED
-
The Use of Molecular Radiogenomics in Non-small Cell Lung Cancer
NCT05541744 ·Status: RECRUITING
-
Quantitative Evaluation of the Impact of Relaxing Eligibility Criteria for Lung Cancer Based on Real-world Data
NCT06314542 ·Status: RECRUITING
-
Single Pulmonary Nodule Investigation
NCT02013063 ·Status: UNKNOWN
-
Understanding Lung Cancer Related Risk Factors and Their Impact
NCT06473870 ·Status: NOT_YET_RECRUITING
-
Multiple Omics Sequencing Technologies in Predicting the Efficacy and Monitoring the Recurrence of Non-Small Cell Lung Cancer
NCT07057102 ·Status: RECRUITING
-
Assessment of Novel Biomarkers in Participants Undergoing Targeted Lung Health Checks
NCT05902559 ·Status: RECRUITING
-
Analysis of Screen-detected Lung Cancers' Genomic Traits
NCT04204499 ·Status: ACTIVE_NOT_RECRUITING
-
Analysis of Volatile Chemicals in Lung Cancer Screen-Eligible Subjects Using Infrared Spectroscopy
NCT05174468 ·Status: TERMINATED
-
Significance of MRD After Surgery in Driver Gene-positive and Driver Gene-negative Stage IB-IIA NSCLC
NCT05441566 ·Status: ENROLLING_BY_INVITATION
-
Lung Cancer Informational Study (LCIS)
NCT00579215 ·Status: COMPLETED ·Phase: NA
-
Analysis of Plasma Tumor DNA in Lung Cancer Patients
NCT01930474 ·Status: UNKNOWN